STUDY ON BI 54903 (INHALED CORTICOSTEROID) ADMINISTERED ONCE DAILY OR TWICE DAILY VIA RESPIMAT INHALER IN PATIENTS WITH ASTHMA INADEQUATELY CONTROLLED ON SHORT ACTING BETA-2 AGONIST (SABA) THERAPY ALONE: